Allergan CEO Brent Saunders thinks aesthetic medical treatments are the next big moneymaker — 4 key notes

Allergan’s CEO Brent Saunders said on CNBC male millennials are revitalizing the aesthetic medical treatment market.

Advertisement

Here’s what you should know:

1. While 30 million U.S. residents consider aesthetic treatments, only 3 million complete the procedures.

2. Mr. Saunders said within that 3 million however male millennials account for 25 percent of the market.

3. The emergence of the male millennial markets is new to aesthetic medicine, but Mr. Saunders said it’s rapidly expanding.

4. Allergan’s Botox was the company’s sales leader last quarter. Allergan recently closed a $2.48 billion acquisition of Zeltiq. Zeltiq’s primary product space is in medical aesthetics.

More articles on improving performance:
7 things for ASC leaders to know for Thursday — Aug. 10, 2017
Buena Vista Surgery increases case volume by 10% by making it easier for physician offices to coordinate cases: 4 key takeaways
MedHQ names new human resources director: 3 quick notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.